Cisplatin/gemcitabine/Gimeracil/oteracil/tegafurGrade 3 thrombocytopenia and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1977卷 / 1期

关键词：

D O I：

10.1007/s40278-023-47176-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：102 / 102

相关论文

共 50 条

[41] Cisplatin/docetaxel/gimeracil/oteracil/tegafurVarious toxicities: case report
Reactions Weekly, 2017, 1661 (1) : 86 - 86
[42] Cisplatin/gimeracil/oteracil/tegafur/paclitaxelAnaemia and neutropenia: case report
Reactions Weekly, 2016, 1612 (1) : 56 - 56
[43] Cisplatin/gimeracil/oteracil/tegafurAppetite loss and dysgeusia: case report
Reactions Weekly, 2017, 1657 (1) : 131 - 131
[44] Cisplatin/gimeracil/oteracil/tegafurPerforation of gastric cancer: case report
Reactions Weekly, 2018, 1705 (1) : 95 - 95
[45] Cisplatin/gimeracil/oteracil/tegafurAcute coronary syndrome: case report
Reactions Weekly, 2018, 1685 (1) : 61 - 61
[46] Cisplatin/gimeracil/oteracil/tegafurAnorexia and elevated ALP: case report
Reactions Weekly, 2019, 1740 (1) : 98 - 98
[47] Cisplatin/gimeracil/oteracil/tegafurThrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2018, 1704 (1) : 103 - 103
[48] Gimeracil/oteracil/tegafurLeucopenia, anaemia and thrombocytopenia: 3 case reports
Reactions Weekly, 2019, 1769 (1) : 219 - 219
[49] Cisplatin/gemcitabine/pembrolizumabCandidaemia and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 168 - 168
[50] Cisplatin/gimeracil/oteracil/tegafur/sorafenibLack of efficacy, metabolic encephalopathy and erythema multiforme: case report
Reactions Weekly, 2024, 2023 (1) : 113 - 113

← 1 2 3 4 5 →